Multimodal deep learning with routine clinical data for recurrence risk stratification in HR+/HER2- early breast cancer
Research · 14.01.2026
DOI: 10.34133/research.1136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research, online erschienen am 14.01.2026. Verfasst von Xiaoyan Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
- Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, China.
- College of Computer Science, Sichuan University, Chengdu, China.
- Department of Medical Ultrasound, West China Hospital, Sichuan University, Chengdu, China.
- College of Computer Science and Technology, Chongqing University of Posts and Telecommunications, Chongqing, China.
Zitieren
APA
Wu, X., Liu, H., Liu, J., Mu, B., Li, J., Wang, S., Li, F., Lu, X., Chen, J., Peng, Y., Yi, Y., Lv, J., & Bu, H. (2026). Multimodal deep learning with routine clinical data for recurrence risk stratification in HR+/HER2- early breast cancer. Research. https://doi.org/10.34133/research.1136
Vancouver
Wu X, Liu H, Liu J, Mu B, Li J, Wang S, et al. Multimodal deep learning with routine clinical data for recurrence risk stratification in HR+/HER2- early breast cancer. Research. 2026. doi:10.34133/research.1136
BibTeX
@article{Wu2026,
author = {Wu, Xiaoyan and Liu, Hong and Liu, Jingyan and Mu, Bing'an and Li, Jianfei and Wang, Siyu and Li, Fengling and Lu, Xunxi and Chen, Jie and Peng, Yulan and Yi, Yuhao and Lv, Jiancheng and Bu, Hong},
title = {Multimodal deep learning with routine clinical data for recurrence risk stratification in HR+/HER2- early breast cancer},
journal = {Research},
year = {2026},
doi = {10.34133/research.1136}
}
EUVIMED